2005
DOI: 10.1111/j.1523-5378.2005.00286.x
|View full text |Cite
|
Sign up to set email alerts
|

Amoxicillin Resistance in Helicobacter pylori: Studies from Tokyo, Japan from 1985 to 2003

Abstract: H. pylori resistance to AMPC is still rare in Japan, although the percentage of AMPC-I strains has increased over the last 4 years. The frequency of isolation of strains showing true resistance to AMPC may increase in the future, along with an increase in the frequency of isolation of AMPC-I strains.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 32 publications
0
14
0
Order By: Relevance
“…So far AMO and RIF from this and other studies are those with resistance close to 0%[14]. H. pylori resistance to AMO, despite its wide use in triple therapy worldwide is low, recent reports describe an increased resistance in recent years [15]. RIF, a rifampicin derivative that shows a resistance as low as ampicillin's, is not commonly used due to its potential myelotoxic effect and because it may induce resistance to Mycobacterium tuberculosis.…”
Section: Discussionmentioning
confidence: 92%
“…So far AMO and RIF from this and other studies are those with resistance close to 0%[14]. H. pylori resistance to AMO, despite its wide use in triple therapy worldwide is low, recent reports describe an increased resistance in recent years [15]. RIF, a rifampicin derivative that shows a resistance as low as ampicillin's, is not commonly used due to its potential myelotoxic effect and because it may induce resistance to Mycobacterium tuberculosis.…”
Section: Discussionmentioning
confidence: 92%
“…However, the eradication rate associated with this triple therapy is low in patients infected with clarithromycinresistant strains of H. pylori (5). The incidence of clarithromycin-resistant strains has increased in Japan (6). Triple therapy with a PPI, minocycline and metronidazole (7) is also candidate treatment in such cases; however, the eradication rates obtained with this regimen are not always sufficient (6).…”
Section: Introductionmentioning
confidence: 99%
“…The percentage of amoxicillin resistant H. pylori is less than 1% in many regions (15,22,27). However, reports of amoxicillin-resistance in H. pylori have increased recently, and amoxicillin-resistant H. pylori has become the major cause of eradication failure in certain areas (6,16,26). There are two major mechanisms in β-lactam resistance: 1) the presence of β-lactamase that hydrolyzes the β-lactam ring, and 2) alterations in the penicillin-binding proteins (PBPs) which are the targets for β-lactams.…”
mentioning
confidence: 99%